Two different systems exist for subclassification of acute myeloid leukemia (AML); the World
Health Organization (WHO) Classification and the International Consensus Classification …

Objectives: Session 2 of the workshop focused on cases of acute myeloid leukemia (AML)
with gene mutations in the setting of a normal karyotype. Methods: Among 22 AML cases …

Acute myeloid leukemia (AML) is a clonal malignant neoplasm of myeloid cell lineage
primarily involving the peripheral blood and bone marrow, although other tissue …

Abstract Objectives: Session 1 of the 2013 Society for Hematopathology/European
Association for Hematopathology Workshop was devoted to the cases of acute myeloid …

Identification of chromosomal abnormalities in patients with acute myeloid leukemia (AML)
has contributed substantially to our current understanding of the molecular pathogenesis …

The diversity of genetic and genomic abnormalities observed in acute myeloid leukemia
(AML) reflects the complexity of these hematologic neoplasms. The detection of cytogenetic …

Acute myeloid leukemia (AML) is a malignancy that is characterized by molecular and
clinical heterogeneity. Changes to the classification of AML over the last decades are …

Balanced chromosomal rearrangements define distinct entities in acute myeloid leukemia
(AML). Here, we present 13 AML cases with t (8; 16)(p11; p13) with observed low incidence …

Acute myeloid leukemia (AML) is a heterogeneous group of diseases in terms of clinical
presentation, genetic alterations and response to treatment. Cytogenetic abnormalities that …

Objectives To identify and characterize constitutional chromosomal rearrangements that
mimic recurrent genetic abnormalities in acute myeloid leukemia (AML). Methods Bone …